Literature DB >> 26569070

The influence of gut microbiota on drug metabolism and toxicity.

Houkai Li1, Jiaojiao He1, Wei Jia1,2.   

Abstract

INTRODUCTION: Gut microbiota plays critical roles in drug metabolism. The variation of gut microbiota contributes to the interindividual differences toward drug therapy including drug-induced toxicity and efficacy. Accordingly, the investigation and elucidation of gut microbial impacts on drug metabolism and toxicity will not only facilitate the way of personalized medicine, but also improve rational drug design. AREAS COVERED: This review provides an overview of the microbiota-host co-metabolism on drug metabolism and summarizes 30 clinical drugs that are co-metabolized by host and gut microbiota. Moreover, this review is specifically focused on elucidating the gut microbial modulation of some clinical drugs, in which the gut microbial influences on drug metabolism, drug-induced toxicity and efficacy are discussed. EXPERT OPINION: The gut microbial contribution to drug metabolism and toxicity is increasingly recognized, but remains largely unexplored due to the extremely complex relationship between gut microbiota and host. The mechanistic elucidation of gut microbiota in drug metabolism is critical before any practical progress in drug design or personalized medicine could be made by modulating human gut microbiota. Analytical technique innovation is urgently required to strengthen our capability in recognizing microbial functions, including metagenomics, metabolomics and the integration of multidisciplinary knowledge.

Entities:  

Keywords:  drug metabolism; efficacy; gut microbiota; toxicity

Mesh:

Substances:

Year:  2015        PMID: 26569070      PMCID: PMC5683181          DOI: 10.1517/17425255.2016.1121234

Source DB:  PubMed          Journal:  Expert Opin Drug Metab Toxicol        ISSN: 1742-5255            Impact factor:   4.481


  70 in total

Review 1.  Host-gut microbiota metabolic interactions.

Authors:  Jeremy K Nicholson; Elaine Holmes; James Kinross; Remy Burcelin; Glenn Gibson; Wei Jia; Sven Pettersson
Journal:  Science       Date:  2012-06-06       Impact factor: 47.728

Review 2.  The role of drug metabolizing enzymes in clearance.

Authors:  Li Di
Journal:  Expert Opin Drug Metab Toxicol       Date:  2014-01-07       Impact factor: 4.481

Review 3.  Irinotecan in the treatment of colorectal cancer: clinical overview.

Authors:  U Vanhoefer; A Harstrick; W Achterrath; S Cao; S Seeber; Y M Rustum
Journal:  J Clin Oncol       Date:  2001-03-01       Impact factor: 44.544

4.  The anaerobic metabolism of metronidazole forms N-(2-hydroxyethyl)-oxamic acid.

Authors:  R L Koch; P Goldman
Journal:  J Pharmacol Exp Ther       Date:  1979-03       Impact factor: 4.030

5.  Daidzein and genistein are converted to equol and 5-hydroxy-equol by human intestinal Slackia isoflavoniconvertens in gnotobiotic rats.

Authors:  Anastasia Matthies; Gunnar Loh; Michael Blaut; Annett Braune
Journal:  J Nutr       Date:  2011-11-23       Impact factor: 4.798

6.  Effects of gut microflora on pharmacokinetics of hesperidin: a study on non-antibiotic and pseudo-germ-free rats.

Authors:  Ming Ji Jin; Unyong Kim; In Sook Kim; Yuri Kim; Dong-Hyun Kim; Sang Beom Han; Dong-Hyun Kim; Oh-Seung Kwon; Hye Hyun Yoo
Journal:  J Toxicol Environ Health A       Date:  2010

7.  Intestinal anaerobic bacteria hydrolyse sorivudine, producing the high blood concentration of 5-(E)-(2-bromovinyl)uracil that increases the level and toxicity of 5-fluorouracil.

Authors:  H Nakayama; T Kinouchi; K Kataoka; S Akimoto; Y Matsuda; Y Ohnishi
Journal:  Pharmacogenetics       Date:  1997-02

8.  Intestinal bacterial hydrolysis is required for the appearance of compound K in rat plasma after oral administration of ginsenoside Rb1 from Panax ginseng.

Authors:  T Akao; H Kida; M Kanaoka; M Hattori; K Kobashi
Journal:  J Pharm Pharmacol       Date:  1998-10       Impact factor: 3.765

9.  Metabolism of peptide drugs by the microorganisms in rat cecal contents.

Authors:  H Tozaki; Y Emi; E Horisaka; T Fujita; A Yamamoto; S Muranishi
Journal:  Biol Pharm Bull       Date:  1995-06       Impact factor: 2.233

10.  Gut microbiota-mediated drug interactions between lovastatin and antibiotics.

Authors:  Dae-Hyoung Yoo; In Sook Kim; Thi Kim Van Le; Il-Hoon Jung; Hye Hyun Yoo; Dong-Hyun Kim
Journal:  Drug Metab Dispos       Date:  2014-06-19       Impact factor: 3.922

View more
  41 in total

1.  Metabolomics technology and bioinformatics for precision medicine.

Authors:  Rajeev K Azad; Vladimir Shulaev
Journal:  Brief Bioinform       Date:  2019-11-27       Impact factor: 11.622

Review 2.  The Human Microbiome and Understanding the 16S rRNA Gene in Translational Nursing Science.

Authors:  Nancy J Ames; Alexandra Ranucci; Brad Moriyama; Gwenyth R Wallen
Journal:  Nurs Res       Date:  2017 Mar/Apr       Impact factor: 2.381

Review 3.  Gut microbiota modulation of chemotherapy efficacy and toxicity.

Authors:  James L Alexander; Ian D Wilson; Julian Teare; Julian R Marchesi; Jeremy K Nicholson; James M Kinross
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-03-08       Impact factor: 46.802

4.  The Opportunities of Metabolomics in Drug Safety Evaluation.

Authors:  Pengcheng Wang; Amina I Shehu; Xiaochao Ma
Journal:  Curr Pharmacol Rep       Date:  2017-01-03

Review 5.  Comparison of Canine and Human Physiological Factors: Understanding Interspecies Differences that Impact Drug Pharmacokinetics.

Authors:  Marilyn N Martinez; Jonathan P Mochel; Sibylle Neuhoff; Devendra Pade
Journal:  AAPS J       Date:  2021-04-27       Impact factor: 4.009

6.  Gut Microbiota Modulation Attenuated the Hypolipidemic Effect of Simvastatin in High-Fat/Cholesterol-Diet Fed Mice.

Authors:  Xuyun He; Ningning Zheng; Jiaojiao He; Can Liu; Jing Feng; Wei Jia; Houkai Li
Journal:  J Proteome Res       Date:  2017-04-10       Impact factor: 4.466

7.  Interaction of antidiabetic α-glucosidase inhibitors and gut bacteria α-glucosidase.

Authors:  Kemin Tan; Christine Tesar; Rosemarie Wilton; Robert P Jedrzejczak; Andrzej Joachimiak
Journal:  Protein Sci       Date:  2018-07-10       Impact factor: 6.725

8.  Presence or absence of microbiome modulates the response of mice organism to administered drug nabumetone.

Authors:  L Jourová; B Lišková; K Lněničková; N Zemanová; P Anzenbacher; P Hermanová; T Hudcovic; H Kozáková; E Anzenbacherová
Journal:  Physiol Res       Date:  2020-12-31       Impact factor: 1.881

Review 9.  The hepatotoxicity of Polygonum multiflorum: The emerging role of the immune-mediated liver injury.

Authors:  Tai Rao; Ya-Ting Liu; Xiang-Chang Zeng; Chao-Peng Li; Dong-Sheng Ou-Yang
Journal:  Acta Pharmacol Sin       Date:  2020-03-02       Impact factor: 6.150

Review 10.  Pharmacological Efficacy/Toxicity of Drugs: A Comprehensive Update About the Dynamic Interplay of Microbes.

Authors:  Juan Antonio Gimenez-Bastida; Lucia Martinez Carreras; Angela Moya-Pérez; José Moisés Laparra Llopis
Journal:  J Pharm Sci       Date:  2017-10-26       Impact factor: 3.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.